Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 12;6(7):e010831.
doi: 10.1136/bmjopen-2015-010831.

Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study

Hisham Aljadhey  1 , Mansour A Mahmoud  1 , Yusuf Ahmed  1 , Razia Sultana  2 , Salah Zouein  2 , Sulafah Alshanawani  3 , Ahmed Mayet  4 , Mashael K Alshaikh  4 , Nora Kalagi  1 , Esraa Al Tawil  4 , Abdul Rahman El Kinge  2 , Abdulmajid Arwadi  2 , Maha Alyahya  5 , Michael D Murray  6 , David Bates  7
Affiliations

Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study

Hisham Aljadhey et al. BMJ Open. .

Abstract

Objectives: To determine the incidence of adverse drug events (ADEs) and assess their severity and preventability in four Saudi hospitals.

Design: Prospective cohort study.

Setting: The study included patients admitted to medical, surgical and intensive care units (ICUs) of four hospitals in Saudi Arabia. These hospitals include a 900-bed tertiary teaching hospital, a 400-bed private hospital, a 1400-bed large government hospital and a 350-bed small government hospital.

Participants: All patients (≥12 years) admitted to the study units over 4 months.

Primary and secondary outcome measures: Incidents were collected by pharmacists and reviewed by independent clinicians. Reviewers classified the identified incidents as ADEs, potential ADEs (PADEs) or medication errors and then determined their severity and preventability.

Results: We followed 4041 patients from admission to discharge. Of these, 3985 patients had complete data for analysis. The mean±SD age of patients in the analysed cohort was 43.4±19.0 years. A total of 1676 ADEs were identified by pharmacists during the medical chart review. Clinician reviewers accepted 1531 (91.4%) of the incidents identified by the pharmacists (245 ADEs, 677 PADEs and 609 medication errors with low risk of causing harm). The incidence of ADEs was 6.1 (95% CI 5.4 to 6.9) per 100 admissions and 7.9 (95% CI 6.9 to 8.9) per 1000 patient-days. The occurrence of ADEs was most common in ICUs (149 (60.8%)) followed by medical (67 (27.3%)) and surgical (29 (11.8%)) units. In terms of severity, 129 (52.7%) of the ADEs were significant, 91 (37.1%) were serious, 22 (9%) were life-threatening and three (1.2%) were fatal.

Conclusions: We found that ADEs were common in Saudi hospitals, especially in ICUs, causing significant morbidity and mortality. Future studies should focus on investigating the root causes of ADEs at the prescribing stage, and development and testing of interventions to minimise harm from medications.

Keywords: Adverse Drug Events (ADEs); Saudi Arabia; prospective cohort study.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow chart.
See this image and copyright information in PMC

References

    1. Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307–11. 10.1001/jama.1997.03540280045032 - DOI - PubMed
    1. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29–34. 10.1001/jama.1995.03530010043033 - DOI - PubMed
    1. Al Hamid A, Ghaleb M, Aljadhey H et al. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol 2014;78:202–17. 10.1111/bcp.12293 - DOI - PMC - PubMed
    1. Morimoto T, Sakuma M, Matsui K et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med 2011;26:148–53. 10.1007/s11606-010-1518-3 - DOI - PMC - PubMed
    1. Aljadhey H, Mahmoud MA, Mayet A et al. Incidence of adverse drug events in an academic hospital: a prospective cohort study. Int J Qual Health C 2013;25:648–55. 10.1093/intqhc/mzt075 - DOI - PubMed

Publication types

LinkOut - more resources